In June, Google seems quite fervent and busy in bringing diversity in its offerings. To recall, recently-announced Im2Calories and Which Phone applications of Search Giant have heated up the global village as well as discussions regarding its next-generation Project Tango smartphone are on the peak level. In this sequence, corporation has again stirred in the tech world by revealing about its health tracking wearable.
Well, we have gone through many existing consumer fitness-centric wristbands, but now Google has introduced something more rigorous and accomplished enough. As reported by Bloomberg, corporation's semi-secret facility or we can its research division: Google X has developed an efficient and ultra-modern health-tracking wristband in order to aid the drug makers, researchers and doctors, through which clinical trials, drug tests, catching early signs of disease and keeping eyes on patients' tiny bodily activity will become facile and convenient.
In a telephone interview, head of the life sciences team at Internet Giant, Andy Conrad stated that their novel quest has been developed to bring an ideal medical device that will be prescribed to patients or used for clinical trials, and won't be marketed as a consumer device. The wrist-worn has been integrated with various advanced sensors and cutting-edge technology, whereby gadget can measure pulse, heart rhythm, skin temperature. In addition, it is able to provide environmental information like light exposure and noise levels.
As per company, for the sake of user-friendly design and interface, device doesn't compromise with performance. It has been claimed to produce accurate and reliable data. Most importantly, wrist sensor will also reduce the responsibilities of physicians by gathering all information about diseased person's health minute-by-minute. Furthermore, its Trial tests will start in summer and Google will collaborate with academic researchers and drug makers to test the accuracy of band as well as seek regulatory clearance to use it in U.S. and Europe, says Andy Conrad.
News Source: Bloomberg
Image Source: FoneArena